These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3184274)

  • 1. p56lck protein-tyrosine kinase is cytoskeletal and does not bind to polyomavirus middle T antigen.
    Louie RR; King CS; MacAuley A; Marth JD; Perlmutter RM; Eckhart W; Cooper JA
    J Virol; 1988 Dec; 62(12):4673-9. PubMed ID: 3184274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits.
    Pelchen-Matthews A; Boulet I; Littman DR; Fagard R; Marsh M
    J Cell Biol; 1992 Apr; 117(2):279-90. PubMed ID: 1373141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of p60c-src with polyoma virus middle-T antigen abrogating mitosis-specific activation.
    Kaech S; Covic L; Wyss A; Ballmer-Hofer K
    Nature; 1991 Apr; 350(6317):431-3. PubMed ID: 1707141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxy-terminal sequence of p56lck can regulate p60c-src.
    MacAuley A; Cooper JA
    Mol Cell Biol; 1988 Aug; 8(8):3560-4. PubMed ID: 2463478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the activity and phosphorylation of the lck protein in lymphoid cells.
    Hurley TR; Sefton BM
    Oncogene; 1989 Mar; 4(3):265-72. PubMed ID: 2468122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatically inactive p60c-src mutant with altered ATP-binding site is fully phosphorylated in its carboxy-terminal regulatory region.
    Jove R; Kornbluth S; Hanafusa H
    Cell; 1987 Sep; 50(6):937-43. PubMed ID: 2441875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of tripartite chimeras between Src and Lck.
    Kashishian A; MacAuley A; Cooper JA
    Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features of the carboxy terminus of p60c-src that are required for the regulation of its intrinsic kinase activity.
    Kato J; Hirota Y; Nakamura N; Nakamura N; Takeya T
    Jpn J Cancer Res; 1987 Dec; 78(12):1354-62. PubMed ID: 3123438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTPase-activating protein interactions with the viral and cellular Src kinases.
    Brott BK; Decker S; Shafer J; Gibbs JB; Jove R
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):755-9. PubMed ID: 1704131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc-induced tyrosine phosphorylation of hippocampal p60c-src is catalyzed by another protein tyrosine kinase.
    Vener AV; Loeb J
    FEBS Lett; 1992 Aug; 308(1):91-3. PubMed ID: 1379555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex.
    Barber EK; Dasgupta JD; Schlossman SF; Trevillyan JM; Rudd CE
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3277-81. PubMed ID: 2470098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
    Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
    Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability.
    Kornbluth S; Cheng SH; Markland W; Fukui Y; Hanafusa H
    J Virol; 1990 Apr; 64(4):1584-9. PubMed ID: 1690822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.
    Dunant NM; Senften M; Ballmer-Hofer K
    J Virol; 1996 Mar; 70(3):1323-30. PubMed ID: 8627648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the polyomavirus middle-T antigen with c-yes protein.
    Kornbluth S; Sudol M; Hanafusa H
    Nature; 1987 Jan 8-14; 325(7000):171-3. PubMed ID: 3027584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.
    Thome M; Duplay P; Guttinger M; Acuto O
    J Exp Med; 1995 Jun; 181(6):1997-2006. PubMed ID: 7539035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural differences between repressed and derepressed forms of p60c-src.
    MacAuley A; Cooper JA
    Mol Cell Biol; 1989 Jun; 9(6):2648-56. PubMed ID: 2474758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.